Signant rolls out cancer trial tech service suite

Signant Health has launched a clinical trial optimization technology that it claims offers sites a more effective way of managing cancer drug research.

The technology – known as Oncology Complete – combines Philadelphia-based Signant’s electronic clinical outcome assessment, consent and study management systems. The firm said that the technology can support both site-based and remote clinical trials.

“At its core is a highly versatile eCOA solution, which fully meets the changing regulatory expectations for patient-reported outcomes measurement in cancer trials, enabling at-home or at-site assessments as well as built-in patient engagement and video visit features to promote a simplified patient experience.”

“For investigative sites, automated data record creation and reconciliation features streamline workflows while promoting protocol adherence such as ensuring compliance with inclusion/exclusion criteria.”

Chief product officer Sanjiv Waghmare, Signant's expanded on this, adding "We're offering a full-featured oncology evidence generation platform combined with Signant's expert service and support, all under one contract.

“From patient-reported outcomes data capture to informed consent, patient engagement, video visits and medication management, our single-source approach enables sponsors to conduct simple and complex trials efficiently and cost-effectively."

According to Signant, the core technology have been used in more than 1,000 cancer trials worldwide including early-phase, local studies and pivotal multinational trials.

The firm said it has worked with over 400 sponsors - including all top 20 pharmaceutical companies – as well as contract research organisations (CRO) of all sizes.

Expansion

Signant has been expanding its business since 2020 when it acquired decentralized clinical trial software developer, VirTrial.

Since then the firm has launched an acceleration program that reduces CNS drug reduces study setup timelines by 50% and made a strategic investment in data analytics and aggregation firm ThoughtSphere.

Of the latter partnership, Signant said the aim was to offer customers additional opportunities beyond data capture to cover the full continuum of the patient-data journey, up to the point of regulatory dossier and submission.

And in January, Signant was selected as a technology vendor by the Trials@Home consortium, an industry backed group focused on boosting inclusion in clinical research.

Image: Stock Photo Secrets